These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18239468)

  • 1. DEAD-box RNA helicase p68 is not required for nuclear translocation of beta-catenin in colon cancer cells.
    Stucke VM; Gorses D; Hofmann F
    Cell Cycle; 2008 Mar; 7(6):830-2. PubMed ID: 18239468
    [No Abstract]   [Full Text] [Related]  

  • 2. P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from beta-catenin.
    Yang L; Lin C; Liu ZR
    Cell; 2006 Oct; 127(1):139-55. PubMed ID: 17018282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA helicase p68 deploys β-catenin in regulating RelA/p65 gene expression: implications in colon cancer.
    Khare V; Tabassum S; Chatterjee U; Chatterjee S; Ghosh MK
    J Exp Clin Cancer Res; 2019 Jul; 38(1):330. PubMed ID: 31351496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DEAD-box RNA helicase DDX5 (p68) and β-catenin: The crucial regulators of FOXM1 gene expression in arbitrating colorectal cancer.
    Tabassum S; Basu M; Ghosh MK
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194933. PubMed ID: 36997114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unwinding a path to nuclear beta-catenin.
    He X
    Cell; 2006 Oct; 127(1):40-2. PubMed ID: 17018273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The DEAD box protein p68: a crucial regulator of AKT/FOXO3a signaling axis in oncogenesis.
    Sarkar M; Khare V; Guturi KK; Das N; Ghosh MK
    Oncogene; 2015 Nov; 34(47):5843-56. PubMed ID: 25745998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Anti-Cancer Agent, 1-(3,5-Dimethoxyphenyl)-4-[(6-Fluoro-2-Methoxyquinoxalin-3-yl)Aminocarbonyl] Piperazine (RX-5902), Interferes With β-Catenin Function Through Y593 Phospho-p68 RNA Helicase.
    Kost GC; Yang MY; Li L; Zhang Y; Liu CY; Kim DJ; Ahn CH; Lee YB; Liu ZR
    J Cell Biochem; 2015 Aug; 116(8):1595-601. PubMed ID: 25649741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated p68 RNA helicase activates Snail1 transcription by promoting HDAC1 dissociation from the Snail1 promoter.
    Carter CL; Lin C; Liu CY; Yang L; Liu ZR
    Oncogene; 2010 Sep; 29(39):5427-36. PubMed ID: 20676135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of RNA helicases p68 and p72 in colon cancer.
    Shin S; Rossow KL; Grande JP; Janknecht R
    Cancer Res; 2007 Aug; 67(16):7572-8. PubMed ID: 17699760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of β-catenin and RX-5902 binding to phospho-p68 RNA helicase by molecular dynamics simulation.
    Ali W; Shafique S; Rashid S
    Prog Biophys Mol Biol; 2018 Dec; 140():79-89. PubMed ID: 29729328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P68 RNA helicase is a nucleocytoplasmic shuttling protein.
    Wang H; Gao X; Huang Y; Yang J; Liu ZR
    Cell Res; 2009 Dec; 19(12):1388-400. PubMed ID: 19786986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DDX17 nucleocytoplasmic shuttling promotes acquired gefitinib resistance in non-small cell lung cancer cells via activation of β-catenin.
    Li K; Mo C; Gong D; Chen Y; Huang Z; Li Y; Zhang J; Huang L; Li Y; Fuller-Pace FV; Lin P; Wei Y
    Cancer Lett; 2017 Aug; 400():194-202. PubMed ID: 28259822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of DEAD-box RNA helicase p68 (DDX5) in the development and treatment of breast cancer.
    Hashemi V; Masjedi A; Hazhir-Karzar B; Tanomand A; Shotorbani SS; Hojjat-Farsangi M; Ghalamfarsa G; Azizi G; Anvari E; Baradaran B; Jadidi-Niaragh F
    J Cell Physiol; 2019 May; 234(5):5478-5487. PubMed ID: 30417346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P68 RNA helicase as a molecular target for cancer therapy.
    Dai TY; Cao L; Yang ZC; Li YS; Tan L; Ran XZ; Shi CM
    J Exp Clin Cancer Res; 2014 Aug; 33(1):64. PubMed ID: 25150365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling to the DEAD box--regulation of DEAD-box p68 RNA helicase by protein phosphorylations.
    Yang L; Lin C; Liu ZR
    Cell Signal; 2005 Dec; 17(12):1495-504. PubMed ID: 15927448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.
    He TY; Wu DW; Lin PL; Wang L; Huang CC; Chou MC; Lee H
    Sci Rep; 2016 Feb; 6():21483. PubMed ID: 26892600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DEAD box protein p68: a novel coactivator of Stat3 in mediating oncogenesis.
    Sarkar M; Khare V; Ghosh MK
    Oncogene; 2017 Jun; 36(22):3080-3093. PubMed ID: 27941883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of indomethacin on E-cadherin and beta-catenin expression in HT-29 colon cancer cells.
    Kapitanović S; Cacev T; Antica M; Kralj M; Cavrić G; Pavelić K; Spaventi R
    Exp Mol Pathol; 2006 Feb; 80(1):91-6. PubMed ID: 15963497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma (PPARgamma) suppresses colonic epithelial cell turnover and colon carcinogenesis through inhibition of the beta-catenin/T cell factor (TCF) pathway.
    Fujisawa T; Nakajima A; Fujisawa N; Takahashi H; Ikeda I; Tomimoto A; Yonemitsu K; Nakajima N; Kudo C; Wada K; Kubota N; Terauchi Y; Kadowaki T; Nakagama H; Blumberg RS
    J Pharmacol Sci; 2008 Apr; 106(4):627-38. PubMed ID: 18391483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.